IVGIX
Price
$22.97
Change
+$0.17 (+0.75%)
Updated
Jan 17 closing price
Net Assets
159.59M
VIVIX
Price
$68.15
Change
+$0.43 (+0.63%)
Updated
Jan 17 closing price
Net Assets
183.52B
Ad is loading...

IVGIX vs VIVIX

Header iconIVGIX vs VIVIX Comparison
Open Charts IVGIX vs VIVIXBanner chart's image
VY® Invesco Growth and Income I
Price$22.97
Change+$0.17 (+0.75%)
VolumeN/A
Net Assets159.59M
Vanguard Value Index I
Price$68.15
Change+$0.43 (+0.63%)
VolumeN/A
Net Assets183.52B
IVGIX vs VIVIX Comparison Chart
Loading...
View a ticker or compare two or three
VS
IVGIX vs. VIVIX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IVGIX is a Buy and VIVIX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIVIX has more cash in the bank: 184B vs. IVGIX (160M). VIVIX pays higher dividends than IVGIX: VIVIX (2.37) vs IVGIX (1.81). IVGIX was incepted earlier than VIVIX: IVGIX (19 years) vs VIVIX (27 years). IVGIX has a lower initial minimum investment than VIVIX: IVGIX (0) vs VIVIX (5000000). VIVIX annual gain was more profitable for investors over the last year : 18.21 vs. IVGIX (9.70). VIVIX return over 5 years is better than : 44.19 vs. IVGIX (8.16).
IVGIXVIVIXIVGIX / VIVIX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence19 years27 years-
Gain YTD3.8903.211121%
Front LoadN/AN/A-
Min. Initial Investment05000000-
Min. Initial Investment IRAN/AN/A-
Net Assets160M184B0%
Annual Yield % from dividends1.812.3777%
Returns for 1 year9.7018.2153%
Returns for 3 years-10.3918.46-56%
Returns for 5 years8.1644.1918%
Returns for 10 years-6.22111.13-6%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AMR192.652.55
+1.34%
Alpha Metallurgical Resources
BV15.980.19
+1.20%
BrightView Holdings
HPQ32.510.16
+0.49%
HP
OBT26.55-0.18
-0.67%
Orange County Bancorp Inc
CGTX0.68-0.01
-1.80%
Cognition Therapeutics